ImmunityBio
IBRX
IBRX
141 hedge funds and large institutions have $209M invested in ImmunityBio in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 35 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
+15
Holders Change %
+11.9%
% of All Funds
2.18%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
34
Increased
47
Reduced
35
Closed
19
Calls
$2.96M
Puts
$7.39M
Net Calls
-$4.44M
Net Calls Change
+$3.53M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$37.8M |
| 2 |
2
Rafferty Asset Management
New York
|
$5.02M |
| 3 |
3
Marshall Wace
London,
United Kingdom
|
$1.48M |
| 4 |
4
Group One Trading
Chicago,
Illinois
|
$1.46M |
| 5 |
5
Millennium Management
New York
|
$1.69M |
